GGrantIndex
Sort

53,477 grants matching addiction

Novel Dopamine D3/D2 Receptor Ligands

$11,662,952
Amy Hauck Newman · National Institute On Drug Abuse · ZIA · FY2023 · DA

New England Regional Primate Research Center

$11,491,726
Harvard University (Medical School) · P51 · FY2004 · RR

New England Primate Research Center Base Grant

$11,246,747
Jeffrey S Flier · Harvard Medical School · P51 · FY2009 · RR

Improving Access and Treatment for Co-occurring Opioid Use Disorders and Mental Illness

$11,232,927
Katherine E Watkins · Rand Corporation · UF1 · FY2019 · MH

Neurobiology of Drug Reward and Addiction

$11,202,189
Nora D. Volkow · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2024 · AA

HEAL Initiative: Antenatal Opioid Exposure Longitudinal Study Consortium

$11,018,358
Carla M Bann · Research Triangle Institute · PL1 · FY2019 · HD

REGIONAL PRIMATE RESEARCH CENTER

$10,950,971
Oregon Health And Science University · P51 · FY2003 · RR

SCREENING OF INVESTIGATIONAL AGENTS THROUGH THE NINDS PRECLINICAL SCREENING PLATFORM FOR PAIN (PSPP)

$10,891,025
Emer Leahy · Psychogenics, Inc. · N01 · FY2021 · DA

The National Drug Abuse Clinical Trials Network: New England Consortium Node

$10,852,537
Gail D'onofrio · Yale University · UG1 · FY2020 · DA

New England Primate Research Center Base Grant

$10,813,961
Jeffrey S Flier · Harvard Medical School · P51 · FY2008 · RR

New England Regional Primate Research Center

$10,619,873
Jeffrey S Flier · Harvard Medical School · P51 · FY2007 · RR

New England Regional Primate Research Center

$10,619,873
Joseph B Martin · Harvard Medical School · P51 · FY2006 · RR

Iron-CLAD: securely advancing AoU participant characterization with provenplatforms and collaborations

$10,617,863
Melissa A Haendel · University Of Colorado Denver · OT2 · FY2023 · OD

NIDA Clinical Trials Network: Big South/West Node

$10,575,670
Madhukar H Trivedi · Ut Southwestern Medical Center · UG1 · FY2021 · DA

Helping to End Addiction Long-term (HEAL): Development of Clinical Candidate Drugs for Pain, Addiction and Overdose

$10,316,802
Donald Lo · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR

Cannabidiol in the treatment of opioid use disorder

$10,316,590
Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai · UH3 · FY2024 · DA

HEAL: Development of Clinical Candidate Drugs for Pain, Addiction and Overdose

$10,299,226
Donald Lo · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR

Data Coordinating Center (DCC) for the Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial (NOWS PhaCET)

$10,225,990
Abhik Das · Research Triangle Institute · U24 · FY2023 · HD

New England Regional Primate Research Center

$10,221,526
Harvard University (Medical School) · P51 · FY2005 · RR

VA-Perry Point Cooperative Studies Program

$10,207,014
National Institute On Drug Abuse · Y01 · FY2013 · DA

Data Coordinating Center for the NICHD Neonatal Research Network (U24)

$10,200,000
Abhik Das · Research Triangle Institute · U24 · FY2021 · HD

Neurobiology of Drug Reward and Addiction

$10,185,436
Nora D. Volkow · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2025 · AA

Neurobiology of Drug Reward and Addiction

$10,133,849
Nora D. Volkow · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2023 · AA

Data Coordinating Center (DCC) for Completion of Ongoing MFMU Network Protocols (U24 Clinical Trial Optional)

$9,915,568
Rebecca Gersnoviez Clifton · George Washington University · U24 · FY2022 · HD

REGIONAL PRIMATE RESEARCH CENTER

$9,789,737
Oregon Health And Science University · P51 · FY2002 · RR